Chimeric Antigen Receptor T-Cells: Successful Translation of the First Cell and Gene Therapy From Bench to Bedside

Clin Transl Sci. 2018 Nov;11(6):537-539. doi: 10.1111/cts.12586. Epub 2018 Sep 22.
No abstract available

Publication types

  • Historical Article
  • Research Support, N.I.H., Extramural

MeSH terms

  • Clinical Trials as Topic
  • Genetic Therapy / history
  • Genetic Therapy / legislation & jurisprudence
  • Genetic Therapy / methods*
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Immunotherapy, Adoptive / history
  • Immunotherapy, Adoptive / legislation & jurisprudence
  • Immunotherapy, Adoptive / methods*
  • Leukemia, B-Cell / genetics
  • Leukemia, B-Cell / immunology
  • Leukemia, B-Cell / therapy*
  • Receptors, Chimeric Antigen / genetics
  • Receptors, Chimeric Antigen / immunology*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / transplantation*
  • United States
  • United States Food and Drug Administration

Substances

  • Receptors, Chimeric Antigen